netFormulary Oxfordshire Clinical Commissioning Group NHS
Formulary  
 Search
 Formulary Chapter 6: Endocrine system - Full Chapter
06.01.02.03  Expand sub section  Other antidiabetic drugs
06.01.02.03  Expand sub section  Alpha glucosidase inhibitors
06.01.02.03  Expand sub section  DPP4 inhibitors (gliptins)
Alogliptin (Vipidia▼®)
View adult BNF View SPC online View childrens BNF
First Choice
Green

Alogliptin is first choice DPP4i. See OCCG DPP4i switch protocol

APCO November 2018. 

 
Alogliptin and Metformin (Vipdomet®)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Alogliptin is first choice DPP4i. See OCCG DPP4i switch protocol

APCO November 2018. 

 
   
Alogliptin and Pioglitazone (Incresync®)
View adult BNF View SPC online View childrens BNF
Formulary
Green

Alogliptin is first choice DPP4i. See OCCG DPP4i switch protocol

APCO November 2018. 

 
   
Linagliptin (Trajenta®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

For use in patients with renal impairment. See OCCG DPP4i switch protocol

APCO November 2018. 

 
   
Linagliptin and Metformin (Jentadueto®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

For use in patients with renal impairment. See OCCG DPP4i switch protocol

APCO November 2018. 

 
   
Saxagliptin (Onglyza®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Alogliptin is first choice DPP4i. See OCCG DPP4i switch protocol

APCO November 2018. 

 
Link  Serious hypersensitivity reactions & acute pancreatitis - Dear HCP Letter
   
Saxagliptin and metformin (Komboglyze®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Alogliptin is first choice DPP4i. See OCCG DPP4i switch protocol

APCO November 2018. 

 
   
Sitagliptin (Januvia®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Alogliptin is first choice DPP4i. See OCCG DPP4i switch protocol

APCO November 2018. 

 
   
Sitagliptin and Metformin (Janumet®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Alogliptin is first choice DPP4i. See OCCG DPP4i switch protocol

APCO November 2018. 

 
   
Vildagliptin (Galvus®)
View adult BNF View SPC online View childrens BNF
Restricted Drug Restricted
Brown

Alogliptin is first choice DPP4i. See OCCG DPP4i switch protocol

APCO November 2018. 

 
   
06.01.02.03  Expand sub section  GLP1 agonists
06.01.02.03  Expand sub section  Meglitinides to top
06.01.02.03  Expand sub section  SGL2 inhibitors
06.01.02.03  Expand sub section  Thiazolidinediones
 ....
Key
note Notes
Section Title Section Title (top level)
Section Title Section Title (sub level)
First Choice Item First Choice item
Non Formulary Item Non Formulary section
Restricted Drug
Restricted Drug
Unlicensed Drug
Unlicensed
Track Changes
Display tracking information
click to search medicines.org.uk
Link to adult BNF
click to search medicines.org.uk
Link to children's BNF
click to search medicines.org.uk
Link to SPCs
SMC
Scottish Medicines Consortium
Cytotoxic Drug
Cytotoxic Drug
CD
Controlled Drug
High Cost Medicine
High Cost Medicine
Cancer Drugs Fund
Cancer Drugs Fund
NHSE
NHS England
Homecare
Homecare
CCG
CCG

Traffic Light Status Information

Status Description

Red

Red: Medicines which should only be prescribed in secondary care by a specialist.  

Amber Continuation

Amber Continuation: Medicines which should be initiated or recommended by a specialist for continuation in primary care. The specialist must notify the GP that the prescribing responsibility has been transferred.   

Amber Shared Care Protocol

Amber Shared Care Protocol: Medicines which are appropriate to be initiated and stabilised by a specialist, once stabilised the medicine may be appropriate for responsibility to be transferred from secondary to primary care with the agreement of a GP and a formal ‘shared care’ agreement. The shared care protocol must be approved by the Area Prescribing Committee Oxfordshire (APCO).   

Green

Green: Medicines which are suitable for initiation and ongoing prescribing within primary care.   

Brown

Brown: Medicines which should only be prescribed in restricted circumstances.  

Black

Black: Medicines which are not recommended for use because of lack of evidence of clinical effectiveness, cost effectiveness or safety.  

OCCG Green

not used  

netFormulary